{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:26:05Z","timestamp":1793921165918,"version":"4.8.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":1259,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1038\/s41379-019-0258-0","type":"journal-article","created":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T12:04:01Z","timestamp":1554465841000},"page":"1210-1216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Cytomegalovirus reactivation in inflammatory bowel disease: an uncommon occurrence related to corticosteroid dependence"],"prefix":"10.1016","volume":"32","author":[{"given":"Erika","family":"Hissong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhonda K.","family":"Yantiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-019-0258-0_bib1","first-page":"103","article-title":"Complement-fixing antibodies against cytomegalovirus in different parts of the world","volume":"49","author":"Krech","year":"1973","journal-title":"Bull World Health Organ"},{"issue":"Suppl 2","key":"10.1038\/s41379-019-0258-0_bib2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1386-6532(02)00091-4","article-title":"Diagnosis and treatment approaches of cytomegalovirus infections in adult patients","volume":"25","author":"de la Hoz","year":"2002","journal-title":"J Clin Virol"},{"key":"10.1038\/s41379-019-0258-0_bib3","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/infdis\/153.3.478","article-title":"Risk factors for cytomegalovirus infection after human marrow transplantation","volume":"153","author":"Meyers","year":"1986","journal-title":"J Infect Dis"},{"key":"10.1038\/s41379-019-0258-0_bib4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0166-3542(98)00044-8","article-title":"Summary of the II international symposium on cytomegalovirus","volume":"39","author":"de Jong","year":"1998","journal-title":"Antivir Res"},{"key":"10.1038\/s41379-019-0258-0_bib5","doi-asserted-by":"crossref","first-page":"924","DOI":"10.7326\/0003-4819-119-9-199311010-00010","article-title":"Gastrointestinal cytomegalovirus disease","volume":"119","author":"Goodgame","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1038\/s41379-019-0258-0_bib6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0047-6374(00)00210-4","article-title":"Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study","volume":"121","author":"Olsson","year":"2000","journal-title":"Mech Ageing Dev"},{"key":"10.1038\/s41379-019-0258-0_bib7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1743-422X-10-43","article-title":"The prevalence and risk factors of cytomegalovirus infection in inflammatory bowel disease in Wuhan, Central China","volume":"10","author":"Yi","year":"2013","journal-title":"Virol J"},{"key":"10.1038\/s41379-019-0258-0_bib8","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/ibd.20498","article-title":"Cytomegalovirus infection in ulcerative colitis: a prospective, comparative study on prevalence and diagnostic strategy","volume":"14","author":"Domenech","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1038\/s41379-019-0258-0_bib9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/MCG.0b013e3182160c9c","article-title":"The prevalence and efficacy of ganciclovir on steroid-refractory ulcerative colitis with cytomegalovirus infection: a prospective multicenter study","volume":"46","author":"Kim","year":"2012","journal-title":"J Clin Gastroenterol"},{"key":"10.1038\/s41379-019-0258-0_bib10","first-page":"355","article-title":"Cytomegalovirus infection of the colon: a possible role in exacerbations of inflammatory bowel disease","volume":"80","author":"Berk","year":"1985","journal-title":"Am J Gastroenterol"},{"key":"10.1038\/s41379-019-0258-0_bib11","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1002\/jmv.21877","article-title":"Low frequency of cytomegalovirus infection during exacerbations of inflammatory bowel diseases","volume":"82","author":"Leveque","year":"2010","journal-title":"J Med Virol"},{"key":"10.1038\/s41379-019-0258-0_bib12","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00000478-200403000-00009","article-title":"Cytomegalovirus infection in steroid-refractory ulcerative colitis: a case-control study","volume":"28","author":"Kambham","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-019-0258-0_bib13","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s10620-010-1126-4","article-title":"Cytomegalovirus infection in patients with active inflammatory bowel disease","volume":"55","author":"Kim","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1038\/s41379-019-0258-0_bib14","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.dld.2004.05.013","article-title":"Severe acute colitis associated with cytomegalovirus: a prevalence study","volume":"36","author":"Criscuoli","year":"2004","journal-title":"Dig Liver Dis"},{"key":"10.1038\/s41379-019-0258-0_bib15","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1111\/j.1572-0241.2006.00869.x","article-title":"Cytomegalovirus colitis complicating inflammatory bowel disease","volume":"101","author":"Kandiel","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1038\/s41379-019-0258-0_bib16","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00042560-199704150-00005","article-title":"Definition and diagnosis of cytomegalovirus colitis in patients infected by human immunodeficiency virus","volume":"14","author":"Beaugerie","year":"1997","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1038\/s41379-019-0258-0_bib17","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0016-5085(77)80021-8","article-title":"Cytomegalovirus inclusions in patients with ulcerative colitis and toxic dilation requiring colonic resection","volume":"72","author":"Cooper","year":"1977","journal-title":"Gastroenterology"},{"key":"10.1038\/s41379-019-0258-0_bib18","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.3748\/wjg.v22.i3.1321","article-title":"Cytomegalovirus in inflammatory bowel disease: a systematic review","volume":"22","author":"Romkens","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1038\/s41379-019-0258-0_bib19","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1097\/MIB.0b013e31828075ce","article-title":"Looking for endoscopic features of cytomegalovirus colitis: a study of 187 patients with active ulcerative colitis, positive and negative for cytomegalovirus","volume":"19","author":"Iida","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1038\/s41379-019-0258-0_bib20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cgh.2014.05.026","article-title":"A model for identifying cytomegalovirus in patients with inflammatory bowel disease","volume":"13","author":"McCurdy","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"10.1038\/s41379-019-0258-0_bib21","first-page":"S29","article-title":"Cytomegalovirus colitis in AIDS: presentation in 44 patients and a review of the literature","volume":"4","author":"Dieterich","year":"1991","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1038\/s41379-019-0258-0_bib22","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/modpathol.2017.149","article-title":"Identification of clinically relevant cytomegalovirus infections in patients with inflammatory bowel disease","volume":"31","author":"Wethkamp","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-019-0258-0_bib23","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1172\/JCI119871","article-title":"Interferon-gamma and tumor necrosis factor-alpha specifically induce formation of cytomegalovirus-permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines","volume":"100","author":"Soderberg-Naucler","year":"1997","journal-title":"J Clin Investig"},{"key":"10.1038\/s41379-019-0258-0_bib24","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1128\/JVI.79.1.326-340.2005","article-title":"Role for tumor necrosis factor alpha in murine cytomegalovirus transcriptional reactivation in latently infected lungs","volume":"79","author":"Simon","year":"2005","journal-title":"J Virol"},{"key":"10.1038\/s41379-019-0258-0_bib25","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/00007890-199409000-00007","article-title":"Cytomegalovirus infection in transplant recipients. The role of tumor necrosis factor","volume":"58","author":"Fietze","year":"1994","journal-title":"Transplantation"},{"key":"10.1038\/s41379-019-0258-0_bib26","first-page":"1951","article-title":"Establishment of a novel mouse model of ulcerative colitis with concomitant cytomegalovirus infection: in vivo identification of cytomegalovirus persistent infected cells","volume":"19","author":"Matsumura","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1038\/s41379-019-0258-0_bib27","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0140-6736(94)91116-9","article-title":"Cytomegalovirus reactivation and tumour necrosis factor","volume":"343","author":"Docke","year":"1994","journal-title":"Lancet"},{"key":"10.1038\/s41379-019-0258-0_bib28","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1007\/s10620-010-1162-0","article-title":"Low prevalence of cytomegalovirus infection in patients with Crohn's disease in comparison with ulcerative colitis: effect of different immune response on prevalence of cytomegalovirus infection","volume":"55","author":"Nakase","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1038\/s41379-019-0258-0_bib29","doi-asserted-by":"crossref","first-page":"698","DOI":"10.4049\/jimmunol.181.1.698","article-title":"Transcriptome analysis reveals human cytomegalovirus reprograms monocyte differentiation toward an M1 macrophage","volume":"181","author":"Chan","year":"2008","journal-title":"J Immunol"},{"key":"10.1038\/s41379-019-0258-0_bib30","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000053966","article-title":"Human cytomegalovirus latency and reactivation: a delicate balance between the virus and its host's immune system","volume":"42","author":"Soderberg-Naucler","year":"1999","journal-title":"Intervirology"},{"key":"10.1038\/s41379-019-0258-0_bib31","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1073\/pnas.95.7.3937","article-title":"Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells","volume":"95","author":"Hahn","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/s41379-019-0258-0_bib32","first-page":"S59","article-title":"Intractable ulcerative colitis caused by cytomegalovirus infection: a prospective study on prevalence, diagnosis, and treatment","volume":"46","author":"Wada","year":"2003","journal-title":"Dis Colon Rectum"},{"key":"10.1038\/s41379-019-0258-0_bib33","doi-asserted-by":"crossref","first-page":"e3634","DOI":"10.1371\/journal.pone.0003634","article-title":"Levels of cytomegalovirus specific CD4 T cells are dynamic and correlate with cytomegalovirus viremia after allogeneic stem cell transplantation","volume":"3","author":"Widmann","year":"2008","journal-title":"PLoS One"},{"key":"10.1038\/s41379-019-0258-0_bib34","article-title":"Glucocorticoids promote neural progenitor cell proliferation derived from human induced pluripotent stem cells","volume":"3","author":"Ninomiya","year":"2014","journal-title":"+"},{"key":"10.1038\/s41379-019-0258-0_bib35","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1572-0241.2001.03620.x","article-title":"Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis","volume":"96","author":"Cottone","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1038\/s41379-019-0258-0_bib36","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00535-018-1439-1","article-title":"Evidence-based clinical practice guidelines for inflammatory bowel disease","volume":"53","author":"Matsuoka","year":"2018","journal-title":"J Gastroenterol"},{"key":"10.1038\/s41379-019-0258-0_bib37","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1053\/j.gastro.2006.01.047","article-title":"American Gastroenterological Association Institute medical position statement on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease","volume":"130","author":"Lichtenstein","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1038\/s41379-019-0258-0_bib38","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/ajg.2011.64","article-title":"Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis","volume":"106","author":"Khan","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1038\/s41379-019-0258-0_bib39","doi-asserted-by":"crossref","unstructured":"Prefontaine E, Sutherland LR, Macdonald JK, et al. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev. 2009; CD000067. https:\/\/doi.org\/10.1002\/14651858.CD000067.","DOI":"10.1002\/14651858.CD000067.pub2"},{"key":"10.1038\/s41379-019-0258-0_bib40","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJM200006013422202","article-title":"A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators","volume":"342","author":"Feagan","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1038\/s41379-019-0258-0_bib41","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199502023320503","article-title":"Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators","volume":"332","author":"Feagan","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1038\/s41379-019-0258-0_bib42","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1053\/j.gastro.2004.07.037","article-title":"The efficacy of azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in patients with Crohn's disease remains uncertain","volume":"127","author":"Sandborn","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1038\/s41379-019-0258-0_bib43","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1365-2249.1993.tb05997.x","article-title":"Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease","volume":"94","author":"Reinecker","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"10.1038\/s41379-019-0258-0_bib44","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/BF01540912","article-title":"Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease","volume":"16","author":"Reimund","year":"1996","journal-title":"J Clin Immunol"},{"key":"10.1038\/s41379-019-0258-0_bib45","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1053\/j.gastro.2007.05.006","article-title":"American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006","volume":"133","author":"Clark","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1038\/s41379-019-0258-0_bib46","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1053\/j.gastro.2005.06.064","article-title":"A randomized, placebo-controlled trial of certolizumab pegol (CDP870) for treatment of Crohn's disease","volume":"129","author":"Schreiber","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1038\/s41379-019-0258-0_bib47","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2006.11.041","article-title":"Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial","volume":"132","author":"Colombel","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1038\/s41379-019-0258-0_bib48","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJMoa030815","article-title":"Infliximab maintenance therapy for fistulizing Crohn's disease","volume":"350","author":"Sands","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1038\/s41379-019-0258-0_bib49","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","article-title":"Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial","volume":"359","author":"Hanauer","year":"2002","journal-title":"Lancet"},{"key":"10.1038\/s41379-019-0258-0_bib50","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/ajg.2012.89","article-title":"A pooled analysis of infections, malignancy, and mortality in infliximab- and immunomodulator-treated adult patients with inflammatory bowel disease","volume":"107","author":"Lichtenstein","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1038\/s41379-019-0258-0_bib51","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.crohns.2013.12.013","article-title":"Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease","volume":"8","author":"Rahier","year":"2014","journal-title":"J Crohns Colitis"},{"key":"10.1038\/s41379-019-0258-0_bib52","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1365-2036.2009.04112.x","article-title":"Review article: chronic viral infection in the anti-tumour necrosis factor therapy era in inflammatory bowel disease","volume":"31","author":"Shale","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1038\/s41379-019-0258-0_bib53","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1002\/art.21137","article-title":"Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden","volume":"52","author":"Askling","year":"2005","journal-title":"Arthritis Rheumatol"},{"key":"10.1038\/s41379-019-0258-0_bib54","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s10067-012-1960-1","article-title":"Hepatitis B virus reactivation in rheumatoid arthritis and ankylosing spondylitis patients treated with anti-TNFalpha agents: a retrospective analysis of 49 cases","volume":"31","author":"Ryu","year":"2012","journal-title":"Clin Rheumatol"},{"key":"10.1038\/s41379-019-0258-0_bib55","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.cgh.2016.04.039","article-title":"Biologic therapies and risk of infection and malignancy in patients with inflammatory bowel disease: a systematic review and network meta-analysis","volume":"14","author":"Bonovas","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1038\/s41379-019-0258-0_bib56","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/ibd.20131","article-title":"Infliximab and the risk of latent viruses reactivation in active Crohn's disease","volume":"13","author":"Lavagna","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1038\/s41379-019-0258-0_bib57","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3904\/kjim.2017.087","article-title":"Approach to cytomegalovirus infections in patients with ulcerative colitis","volume":"32","author":"Park","year":"2017","journal-title":"Korean J Intern Med"},{"key":"10.1038\/s41379-019-0258-0_bib58","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jcv.2008.06.002","article-title":"Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNFalpha therapy","volume":"43","author":"D'Ovidio","year":"2008","journal-title":"J Clin Virol"},{"key":"10.1038\/s41379-019-0258-0_bib59","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/ibd.20742","article-title":"Cytomegalovirus disappearance after treatment for refractory ulcerative colitis in 2 patients treated with infliximab and 1 patient with leukapheresis","volume":"15","author":"Criscuoli","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"10.1038\/s41379-019-0258-0_bib60","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/ibd.21047","article-title":"TNF-alpha is an important pathogenic factor contributing to reactivation of cytomegalovirus in inflamed mucosa of colon in patients with ulcerative colitis: lesson from clinical experience","volume":"16","author":"Nakase","year":"2010","journal-title":"Inflamm Bowel Dis"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41379-019-0258-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-019-0258-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222010377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222010377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-019-0258-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:44:32Z","timestamp":1760229872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222010377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":60,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0893395222010377"],"URL":"https:\/\/doi.org\/10.1038\/s41379-019-0258-0","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytomegalovirus reactivation in inflammatory bowel disease: an uncommon occurrence related to corticosteroid dependence","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-019-0258-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}